- Disease: Respiratory syncytial virus infection
- Study type: Observational Cohort Study, Prevention
- Study type descriptors: Retrospective, Multicentre
- Objective: To quantify the association of nirsevimab prophylaxis with RSV-related hospitalisation and RSV severity during the first winter of life, and to explore the independent contributions of prematurity and household exposure (older siblings) to RSV hospitalisation risk and disease severity
- Number of participants enrolled: 13624
- Study enrolling from to
- Study includes follow-up for 1 year
Study Data
- General population
- Infants (<1 year)
- Hospital
- Respiratory syncytial virus
- Respiratory syncytial virus infection
- Pharmacological intervention
- Monoclonal antibodies
- Nirsevimab
External Links
Other information
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to